| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-802-53 | 62135-802 | HUMAN PRESCRIPTION DRUG | Carbamazepine | Carbamazepine | SUSPENSION | ORAL | 20231201 | N/A | ANDA | ANDA075714 | Chartwell RX, LLC | CARBAMAZEPINE | 100 mg/5mL | 450 mL in 1 BOTTLE (62135-802-53) |
| 62135-867-24 | 62135-867 | HUMAN PRESCRIPTION DRUG | Carbamazepine | Carbamazepine | SUSPENSION | ORAL | 20240528 | N/A | ANDA | ANDA075714 | Chartwell RX, LLC | CARBAMAZEPINE | 200 mg/10mL | 2 TRAY in 1 BOX (62135-867-24) / 10 PACKAGE in 1 TRAY / 10 mL in 1 PACKAGE (62135-867-59) |
| 62135-802-24 | 62135-802 | HUMAN PRESCRIPTION DRUG | Carbamazepine | Carbamazepine | SUSPENSION | ORAL | 20240528 | N/A | ANDA | ANDA075714 | Chartwell RX, LLC | CARBAMAZEPINE | 100 mg/5mL | 2 TRAY in 1 BOX (62135-802-24) / 10 PACKAGE in 1 TRAY / 5 mL in 1 PACKAGE (62135-802-45) |